Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 May 29:338:b1846.
doi: 10.1136/bmj.b1846.

Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial

Collaborators, Affiliations
Randomized Controlled Trial

Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial

Geir Hoff et al. BMJ. .

Abstract

Objective: To determine the risk of colorectal cancer after screening with flexible sigmoidoscopy.

Design: Randomised controlled trial.

Setting: Population based screening in two areas in Norway-city of Oslo and Telemark county (urban and mixed urban and rural populations).

Participants: 55 736 men and women aged 55-64 years.

Intervention: Once only flexible sigmoidoscopy screening with or without a single round of faecal occult blood testing (n=13 823) compared with no screening (n=41 913).

Main outcome measures: Planned end points were cumulative incidence and mortality of colorectal cancer after 5, 10, and 15 years. This first report from the study presents cumulative incidence after 7 years of follow-up and hazard ratio for mortality after 6 years.

Results: No difference was found in the 7 year cumulative incidence of colorectal cancer between the screening and control groups (134.5 v 131.9 cases per 100 000 person years). In intention to screen analysis, a trend towards reduced colorectal cancer mortality was found (hazard ratio 0.73, 95% confidence interval 0.47 to 1.13, P=0.16). For attenders compared with controls, a statistically significant reduction in mortality was apparent for both total colorectal cancer (hazard ratio 0.41, 0.21 to 0.82, P=0.011) and rectosigmoidal cancer (0.24, 0.08 to 0.76, P=0.016).

Conclusions: A reduction in incidence of colorectal cancer with flexible sigmoidoscopy screening could not be shown after 7 years' follow-up. Mortality from colorectal cancer was not significantly reduced in the screening group but seemed to be lower for attenders, with a reduction of 59% for any location of colorectal cancer and 76% for rectosigmoidal cancer in per protocol analysis, an analysis prone to selection bias.

Trial registration: Clinical trials NCT00119912.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

None
Fig 1 Flow chart for Norwegian Colorectal Cancer Prevention trial 1 cohort screened January 1999 to December 2001
None
Fig 2 Cumulative hazard for colorectal cancer in screening and control groups
None
Fig 3 Cumulative hazard for rectosigmoidal cancer among attenders compared with control group

Comment in

References

    1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. - PubMed
    1. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 2000;95:868-77. - PubMed
    1. Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006;355:1863-72. - PubMed
    1. Rozen P, Winawer SJ. Report of the OMED colorectal cancer screening committee meeting, New Orleans, 2004—in collaboration with the IDCA. Eur J Cancer Prev 2004;13:461-4. - PubMed
    1. Winawer SJ, Zauber AG, Ho MN, O’Brian MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81. - PubMed

Publication types

Associated data